FDA Inspection 924832 — Regenerative Biologics, Inc.
The FDA completed an inspection of Regenerative Biologics, Inc. on May 5, 2015 in Melbourne, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 5, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Melbourne, FL (United States)